Obesity is a medical condition in which the body has excess fat deposition. Obesity is commonly caused due to excessive food intake, genetic susceptibility, and lack of physical exercise. The high prevalence of obesity is expected to propel the growth of the global obesity management drugs market over the forecast period. Moreover, R&D in obesity is also expected to aid in the growth of the global obesity management drugs market. Drugs used in the treatment of obesity include Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate, and Liraglutide among others.
Market Size and Key Findings
The Global Obesity Drugs Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Obesity Drugs Market Size (In USD Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
The high prevalence of obesity in emerging economies is expected to propel the growth of the global obesity management drugs market. Moreover, the number of products available in the market is abundant.
Market Restraints
Lack of proper healthcare infrastructure along with improper development and implementation of clinical practice guidelines
Competitive Landscape
Key Players
Major players in Obesity Drugs Market are F Hoffmann La Roche Ltd., GlaxoSmithKline plc., Orexigen Therapeutics, Inc., Arena Pharmaceuticals, Inc., VIVUS, Inc., Novo Nordisk A/S, and Eisai Co., Ltd.
TABLE OF CONTENT
1. Report Description of the Global Obesity Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Obesity Drugs Market Executive Summary
2.1 Global Obesity Drugs Market – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Obesity Drugs Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Obesity Drugs Market Segmentation
4.1 By Drug Type
4.1.1 Bupropion & Naltrexone
4.1.2 Orlistat
4.1.3 Lorcaserin
4.1.4 Phentermine
4.1.5 Topiramate
4.1.6 Liraglutide
4.2 By Distribution Channel
4.2.1 Hospital Pharmacies
4.2.2 Retail Pharmacies
4.2.3 E-commerce
5. Global Obesity Drugs Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Obesity Drugs Market
9. Factors Driving Future Growth
9.1 New Trends and Development Global Obesity Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations
Segmentation
Obesity Drugs Market Segmentation
By Drug Type
Bupropion & Naltrexone
Orlistat
Lorcaserin
Phentermine
Topiramate
Liraglutide
By Distribution Channel
Hospitals Pharmacies
Retail Pharmacies
E-commerce
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
